![Abbott gets FDA nod for Infinity DBS in Parkinson's disease, unveils positive data on Proclaim XR | BioWorld Abbott gets FDA nod for Infinity DBS in Parkinson's disease, unveils positive data on Proclaim XR | BioWorld](https://www.bioworld.com/ext/resources/BMT-source/2020/1-24-Abbott-Infinity-DBS-hero.png?1579902035)
Abbott gets FDA nod for Infinity DBS in Parkinson's disease, unveils positive data on Proclaim XR | BioWorld
![Abbott Recalls Neurostim Devices After Complaints of Controllers Disconnecting | Medical Design & Development Abbott Recalls Neurostim Devices After Complaints of Controllers Disconnecting | Medical Design & Development](https://img.medicaldesigndevelopment.com/files/base/indm/multi/image/2023/09/iStock_1181343095.65047c5365007.png?auto=format%2Ccompress&fit=max&q=70&rect=0%2C189%2C2120%2C1192&w=1200)
Abbott Recalls Neurostim Devices After Complaints of Controllers Disconnecting | Medical Design & Development
![FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain - Sep 26, 2019 FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain - Sep 26, 2019](https://www.multivu.com/players/English/8608451-abbott-proclaim-xr-spinal-cord-stimulation-system/image/Photo1_1568661349705-HR.jpg)
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain - Sep 26, 2019
![Comparison of conventional, burst and high-frequency spinal cord stimulation on pain relief in refractory failed back surgery syndrome patients: study protocol for a prospective randomized double-blinded cross-over trial (MULTIWAVE study) | Trials Comparison of conventional, burst and high-frequency spinal cord stimulation on pain relief in refractory failed back surgery syndrome patients: study protocol for a prospective randomized double-blinded cross-over trial (MULTIWAVE study) | Trials](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13063-020-04587-6/MediaObjects/13063_2020_4587_Fig2_HTML.png)
Comparison of conventional, burst and high-frequency spinal cord stimulation on pain relief in refractory failed back surgery syndrome patients: study protocol for a prospective randomized double-blinded cross-over trial (MULTIWAVE study) | Trials
![Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain](https://mma.prnewswire.com/media/271488/Abbott_Logo.jpg?p=facebook)
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
![Abbott's Dorsal Root Ganglion Stimulation Outperforms Traditional Spinal Cord Stimulation | Orthopedic Design Technology Abbott's Dorsal Root Ganglion Stimulation Outperforms Traditional Spinal Cord Stimulation | Orthopedic Design Technology](https://images.rodpub.com/images/140/859_350.jpg)